India Advises Drug Makers To Pass Along Excise Tax Cut
This article was originally published in PharmAsia News
Executive Summary
India is advising drug makers that if they fail to pass along to consumers the reduction in the excise duty they had been charged, the government will consider a 4-5 percent reduction in drug prices. The advisory covers the entire drug industry, including drugs outside government control. The government is said to be considering meeting with drug industry associations before issuing a directive on prices. (Click here for more